EXPERIENCE OF FIFTEEN YEAR USE OF CYCLOSPORIN IN PAEDIATRIE RHEUMATOLOGY
Abstract
Key words: children, juvenile rheumatoid arthritis, cyclosporin, treatment.
About the Authors
E.I. AlexeevaRussian Federation
I.E. Shakhbazyan
Russian Federation
S.I. Valieva
Russian Federation
T.M. Bzarova
Russian Federation
K.B. Isaeva
Russian Federation
A.M. Chomakhidze
Russian Federation
E.Yu. Afonina
Russian Federation
O.S. Rozvadovskaya
Russian Federation
V.Ya. El'yashevich
Russian Federation
D.V. Apaeva
Russian Federation
References
1. Алексеева Е.И., Литвицкий П.Ф.. Ревматоидный артрит. Этиология, патогенез. Клиника. Алгоритмы диагностики и лечения. М.: Веди. 2007. 359 с.
2. Kutukculer N., Caglayan S., Aydogdu F. Study of pro–inflammatory (TNF–alpha, IL–1–alpha, IL–6) and T–cell derived (IL–2, IL–4) cytokines in plasma and synovial fluid of patients with juvenile chronic arthritis: Correlations with clinical and laboratory parameters. Clin. Rheumatol. 1998; 17: 288–292.
3. Mangge H., Kenzian H., Gallistl S. et al. Serum cytokines in juvenile rheumatoid arthritis: correlation with conventional inflammation parameters and clinical subtypes. Arthr. Rheum. 1995; 38: 211–220.
4. Sesin CA, Bingham CO 3rd. Remission in rheumatoid arthritis: wishful thinking or clinical reality? Semin. Arthritis Rheum. 2005; 35 (3): 185–196.
5. Fleischmann R. Safety and efficacy of disease-modifying antirheumatic agents in rheumatoid arthritis and juvenile rheumatoid arthritis. Expert Opin. Drug. Saf. 2003; 2 (4): 347–365.
6. Алексеева Е.И., Шахбазян И.Е. Принципы патогенетической терапии тяжелых системных вариантов ювенильного ревматоидного артрита. Серия «Аутоиммунные болезни». М. 2002. №5. С. 127.
7. Reiff A., Shaham B., Wood B.P. et al. High dose methotrexate in the treatment of refractory juvenile rheumatoid arthritis. Clin. Exp. Rheumatol. 1995; 13 (1): 113–118.
8. Hashkes PJ, Laxer RM. Medical treatment of juvenile idiopathic arthritis. JAMA. 2005; 294 (13): 1671–184.
9. Tambic-Bukovac L., Malcic I., Prohic A. Personal experience with methotrexate in the treatment of idiopathic juvenile arthritis. Reumatizam. 2002; 49 (1): 20–24.
10. Ravelli A, Viola S, Migliavacca D et al. The extended oligoarticular subtype is the best predictor of methotrexate efficacy in juvenile idiopathic arthritis. J. Pediatr. 1999; 135 (3): 316–320.
11. Woo P, Southwood TR, Prieur AM et al. Randomized, placebo controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. Arthr. Rheum. 2000; 43 (8): 1849–1857.
12. Chikanza I.C. Juvenile rheumatoid arthritis: therapeutic perspectives. Paediatr. Drugs. 2002; 4 (5): 335–348.
13. Алексеева Е.И. Принципы патогенетической терапии тяжелых системных вариантов ювенильного ревматоидного артрита. Автореф. дис. … докт. мед. наук. М. 2000. 48 с.
14. Drosos A.A., Voulgari P.V., Katsaraki A. et al. Influence of cyclosporin A on radiological progression in early rheumatoid arthritis patients: a 42 month prospective study. Rheumatol. Int. 2000; 19 (3): 113–118.
15. Drosos AA, Voulgari PV, Papadopoulos IA et al. Cyclosporine A in the treatment of early rheumatoid arthritis. A prospective, randomized 24-month study. Clin. Exp. Rheumatol. 1998; 16 (6): 695–701.
16. Marcos J.C., Maccagno A., Gutfraind E et al. Efficacy, tolerability and safety of cyclosporine for micro emulsion in the treatment of active rheumatoid arthritis. Open study. Medicina (B Aires). 2000; 60 (4): 435–440.
17. Gerloni V., Cimaz R., Gattinara M. et al. Efficacy and safety profile of cyclosporin A in the treatment of juvenile chronic (idiopathic) arthritis. Results of a 10 year prospective study. Rheumatol (Oxford). 2001; 40 (8): 907–913.
18. Haagsma C.J., van Riel P.L. Combination of second line antirheumatic drugs. Ann. Med. 1997; 29 (2): 169–173.
19. Johnsen V., Forre O., Haga H.J. et al. Combination therapy in rheumatoid arthritis. Tidsskr. Nor. Laegeforen. 2003; 123 (11): 1511–1153.
20. Ravelli A., Moretti C., Temporini F. et al. Combination therapy with methotrexate and cyclosporine A in juvenile idiopathic arthritis. Clin. Exp. Rheumatol. 2002; 20 (4): 569–572.
21. Ferraccioli G.F., Gremese E., Tomietto P. et al. Analysis of improvements, full responses, remission and toxicity in rheumatoid patients treated with step-up combination therapy (methotrexate, cyclosporin A, sulphasalazine) or monotherapy for three years. Rheumatol. 2002; 41: 892–898.
22. Tugwell P., Pincus T., Yocum D. et al. Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid Arthritis. N. Engl. J. Rheumatol. 1995; 333 (3): 137–142.
23. Garrood T., Scott D.L. Combination therapy with disease modifying anti-rheumatic drugs in rheumatoid arthritis. Bio Drugs. 2001; 15 (8): 543–561.
24. Sarzi-Puttini P., D'Ingianna E., Fumagalli M. et al. An open, randomized comparison study of cyclosporine A, cyclosporine A + methotrexate and cyclosporine A + hydroxychloroquine in the treatment of early severe rheumatoid arthritis. Rheumatol. Int. 2005; 25(1): 15–22.
25. Darmawan J., Rasker J.J., Nuralim H. Ten year radiographic outcome in patients with rheumatoid factor positive rheumatoid arthritis treated with aggressive immunosuppressive combination therapy. J. Rheumatol. Suppl. 2004; 69: 66–69.
26. Marchesoni A., Battafarano N., Arreghini M. et al. Radiographic progression in early rheumatoid arthritis: a 12 month randomized controlled study comparing the combination of cyclosporin and methotrexate with methotrexate alone. Rheumatol. (Oxford). 2003; 42 (12): 1545–1549.
27. Gerards A.H., Landewé R.B.M., Prins A.P.A. et al. Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial. Ann. Rheum. Dis. 2003; 62: 291–296.
28. Fox RI, Morgan SL, Smith HT et al. Combined oral cyclosporin and methotrexate therapy in patients with rheumatoid arthritis elevates methotrexate levels and reduces 7-hydroxymethotrexate levels when compared with methotrexate alone. Rheumatol. 2003; 42: 989–994.
29. http://rheumatology.oxfordjournals.org/cgi/content/full/42/8/989 - FNC1#FNC1Giacomelli R, Cipriani P, Matucci Cerinic M et al. Combination therapy with cyclosporine and methotrexate in patients with early rheumatoid arthritis soon inhibits TNF-alpha production without decreasing TNF–alpha mRNA levels. An in vivo and in vitro study. Clin. Exp. Rheumatol. 2002; 20 (3): 365–372.
30. Алексеева Е.И. Валиева С.И., Апаева Д.В. Эффективность и безопасность комбинированной иммуносупрессивной терапии циклоспорином и метотрексатом у больных тяжелым ювенильным ревматоидным артритом. Вопросы современной педиатрии. 2006; 5 (2): 19–27.
31. Алексеева Е.И., Валиева С.И., Апаева Д.В. Эффективность различных режимов иммуносупрессивной терапии циклоспорином и метотрексатом у больных системным вариантом ювенильного ревматоидного артрита. Вопросы современной педиатрии. 2007; 6 (2): 29–34.
32. Столяревич Е.С., Сандиммун-Неорал и генеричесие препараты циклоспорина; проблема взаимозаменяемости. Нефрология и диализ. 2006; 8 (2): 141–146.
33. Столяревич Е.С., Суханов А.В., Багдасарян, Томилина Н.А. К вопросу об оптимизации мониторинга терапии препаратами Циклоспорина в поздние сроки после аллотрансплантации почки. Нефрология и диализ. 2004; 6 (2): 145-154.
34. Суханов А.В., Столяревич Е.С., Котенко О.Н., Федорова Н.Д., Томилина Н.А. и соавт. Хроническая нефротоксичность циклоспорина А: функционально-морфологическая характеристика и клинические проявления в поздние сроки после трансплантации почки. Нефрология и диализ. 2004; 6 (2): 170–177.
35. Tanaka Y, Tsujimura S. Clinical implication of cyclosporin for rheumatoid arthritis. Nippon Rinsho. 2002; 60 (12): 2345–2350.
36. Noble S., Markham A. Cyclosporin: a review of its pharmacokinetic proreties, clinical efficacy and tolerability of micriemulsionbased formulation (Neoral). Drugs. 1995; 50: 924–941.
37. Толкушин А.Г., Куликов А.Ю. Материалы международного конгресса развития фармакоэкономики и фармакоэпидемиологии в Российской Федерации. 2006. С. 216–217.
Review
For citations:
Alexeeva E., Shakhbazyan I., Valieva S., Bzarova T., Isaeva K., Chomakhidze A., Afonina E., Rozvadovskaya O., El'yashevich V., Apaeva D. EXPERIENCE OF FIFTEEN YEAR USE OF CYCLOSPORIN IN PAEDIATRIE RHEUMATOLOGY. Current Pediatrics. 2008;7(6):104-117.
Email this article 
